Inovio Biomedical Corp receives USD2.8m grant to develop DNA vaccine for HCV

Submit press release

Existing customer?
Log in

New customer?
Sign up

Latest Headlines
GE Opens First New Manufacturing Operation in Louisville, Ky...
Get set for Bupa Great Birmingham Run...
New Regional Aircraft Contracts and Support...
Harris Corporation's John Shipley Honored by U.S...
Farmers can use red diesel to help out during extreme weather...
Hogan Lovells' It's Not Just Peanuts Campaign Wins Legal Business...

M2 Archive: Preview

You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.

Inovio Biomedical Corp receives USD2.8m grant to develop DNA vaccine for HCV
DNA vaccines developer Inovio Biomedical Corp (NYSE Amex:INO) reported on Friday the receipt of a USD2.8m grant to develop a DNA vaccine to treat hepatitis C virus (HCV).
This grant was awarded by the Pennsylvania Department of Health to the company and its collaborators from Drexel University,...

If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search